v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Ordinary shares
Class A Ordinary Shares
Ordinary shares
Class B Ordinary Shares
Ordinary shares
Additional paid-in capital
Accumulated deficit
Noncontrolling interests
Other comprehensive income
Total
Balance at the beginning at Jun. 30, 2023 [1]     $ 3 $ 74,460,844 $ (64,199,776)     $ 10,261,071
Balance at the beginning (in shares) at Jun. 30, 2023 [1]     11,270          
Increase (Decrease) in Shareholders' Equity                
Exercise of warrants     $ 1 1,151,902       1,151,903
Exercise of warrants (in shares)     2,833          
Conversion of convertible debentures into ordinary shares     $ 1 1,224,325       1,224,326
Conversion of convertible debentures into ordinary shares (in shares)     2,267          
Net (loss) income         (17,531,647) $ (753,311)   (18,284,958)
Sales of ordinary shares     $ 3 3,994,219       3,994,222
Sales of ordinary shares (in shares)     9,376          
Issuance of ordinary shares for compensation       73,230       73,230
Issuance of ordinary shares for compensation (in shares)     114          
Warrants issued with convertible debenture       2,560,858       2,560,858
Exchange of warrants for convertible debenture       (71,319)       (71,319)
Noncontrolling interests acquired           250   250
Balance at the end at Jun. 30, 2024 [1]     $ 8 83,394,059 (81,731,423) (753,061)   909,583
Balance at the end (in shares) at Jun. 30, 2024 [1]     25,860          
Increase (Decrease) in Shareholders' Equity                
Exercise of warrants $ 8     (8)        
Exercise of warrants (in shares) 28,742              
Conversion of convertible debentures into ordinary shares $ 43     6,624,637       6,624,680
Conversion of convertible debentures into ordinary shares (in shares) 141,994              
Deemed dividend attributable to down round feature of warrants       2,146,795 (2,146,795)      
Net (loss) income         (4,387,192) 17,286   (4,369,906)
Re-designation of authorized ordinary shares $ 7 $ 1 $ (8)          
Re-designation of authorized ordinary shares (In shares) 23,300 2,560 (25,860)          
Balance at the end at Jun. 30, 2025 [1] $ 58 $ 1   92,165,483 (88,265,410) (735,775)   3,164,357
Balance at the end (in shares) at Jun. 30, 2025 [1] 194,036 2,560            
Increase (Decrease) in Shareholders' Equity                
Exercise of warrants $ 10     (10)        
Exercise of warrants (in shares) 34,665              
Conversion of convertible debentures into ordinary shares $ 151     4,899,231       4,899,382
Conversion of convertible debentures into ordinary shares (in shares) 504,534              
Issuance of Class A Ordinary Shares for debt settlement   $ 4   99,996       100,000
Issuance of Class A Ordinary Shares for debt settlement (in shares)   11,236            
Additional Class A Ordinary Shares issued in lieu of fractional share entitlements arising from the reverse share split (in shares) 11              
Deemed dividend attributable to down round feature of warrants       9,639,519 (9,639,519)      
Issuance of pre-funded warrants for asset purchase       10,525,929       10,525,929
Effects of credit risk change from liabilities measured at fair value             $ 332,960 332,960
Reclassification of change in instrument-specific credit risk             147,041 147,041
Net (loss) income         (14,285,654) (7,711)   (14,293,365)
Balance at the end at Jun. 30, 2026 [1] $ 219 $ 5   $ 117,330,148 $ (112,190,583) $ (743,486) $ 480,001 $ 4,876,304
Balance at the end (in shares) at Jun. 30, 2026 [1] 733,246 13,796            
[1] Giving retroactive effect to the 1-for-60 reverse share split effected on January 20, 2026 and the 1-for-5 reverse share split effected on August 21, 2026